From Casetext: Smarter Legal Research

United States v. Padilla-Martinez

United States District Court, Eastern District of California
Jun 1, 2022
2:19-CR-00159-JAM-CKD (E.D. Cal. Jun. 1, 2022)

Opinion

2:19-CR-00159-JAM-CKD

06-01-2022

UNITED STATES OF AMERICA, Respondent, v. FILEMON PADILLA-MARTINEZ, Movant.


UNITED STATES' MOTION FOR ORDER WAIVING DEFENDANT'S ATTORNEY-CLIENT PRIVILEGE AND PERMITTING DISCOVERY; ORDER [PROPOSED] ORDER

CAROLYN K. DELANEY UNITED STATES MAGISTRATE JUDGE

Movant is a federal prisoner proceeding pro se with a motion to vacate, set aside, or correct his sentence filed pursuant to 28 U.S.C. § 2255. ECF No. 169. The court finds that Movant, having asserted claims of ineffectiveness against his prior trial counsel in his motion to vacate sentence, has waived his attorney-client privilege with respect to communications between him and his previous attorneys, Mr. Christopher Cosca and Mr. Clemente Jimenez. This waiver encompasses any persons employed by or working with counsel as part of the defense team. Mr. Cosca and Mr. Jimenez are hereby permitted to disclose freely to the parties and the court any relevant information responsive to the ineffective assistance of counsel claims raised in grounds 1-5 of Movant's § 2255 motion including the production of e-mails, notes, records, or other documents. See Bittaker v. Woodford, 331 F.3d 715, 721-24 (9th Cir. 2003) (en banc).

Respondent shall limit its use of any information or documents received to answering the ineffective assistance of counsel claims raised in Movant's § 2255.

IT IS SO FOUND AND ORDERED.


Summaries of

United States v. Padilla-Martinez

United States District Court, Eastern District of California
Jun 1, 2022
2:19-CR-00159-JAM-CKD (E.D. Cal. Jun. 1, 2022)
Case details for

United States v. Padilla-Martinez

Case Details

Full title:UNITED STATES OF AMERICA, Respondent, v. FILEMON PADILLA-MARTINEZ, Movant.

Court:United States District Court, Eastern District of California

Date published: Jun 1, 2022

Citations

2:19-CR-00159-JAM-CKD (E.D. Cal. Jun. 1, 2022)